The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

CS-131: One of the Most Significant Advancements in Brachytherapy

By Global Cancer Consortium on March 28, 2012 • ( Leave a comment )

Brachytherapy, a form of radiation therapy where radioactive seeds – or isotopes – are placed near or inside the tumor to emit radiation, is one of the most intriguing both in the medical and investor community.

This Week In Diagnostics

By Global Cancer Consortium on March 26, 2012 • ( Leave a comment )

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Brachytherapy: Why Chemotherapy May Soon Be a Thing of the Past

By Global Cancer Consortium on March 26, 2012 • ( Leave a comment )

Brachytherapy is considered to be one of the oldest techniques for the treatment of various cancers, particularly for prostate cancer.

“Brooklyn Doc Billionaire” Will Unveil Potential Cure For AIDS

By Global Cancer Consortium on March 21, 2012 • ( Leave a comment )

The film will focus on current biotechnology “innovation-stagnation” , the current cost of drug development and its stages, and conflicts of interest based on human defense concepts.

This Week In Diagnostics

By Global Cancer Consortium on March 21, 2012 • ( Leave a comment )

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

March 31 – April 4, 2012 AACR Annual Meeting

By Global Cancer Consortium on March 14, 2012 • ( Leave a comment )

AACR cordially invites you to the AACR Annual Meeting 2012 taking place Saturday, March 31-Wednesday, April 4, 2012, at McCormick Place in Chicago, Illinois. As always, this AACR Annual Meeting will highlight […]

This Week In Diagnostics

By Global Cancer Consortium on March 13, 2012 • ( Leave a comment )

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

This Week In Diagnostics

By Global Cancer Consortium on March 5, 2012 • ( Leave a comment )

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Posts navigation

‹ Newer 1 … 34 35 36 37 38 39 40 41 42 43 44 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.